Markets · Europe · MCE

GRF.MC Grifols

€9.68 -2.65%

Europe · Pharmaceuticals

Log

Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.

-2.65%

YTD

-21.40%

P/E

—

P/B

—

ROE

—

Div yield

—

Beta

0.68

Market cap

—

RSI (14)

Next earnings

—

Previous session

close of Oct 8, 2026 · EOD, no live order book

Open

€9.91

€9.68

VWAP (n/a)

—

Day high

€9.92

Day low

€9.68

Volume

1.2M

VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.

Latest headlines

REPEAT - Grifols deaths and harm: Patient safety & options for accountability

Yahoo Finance · Jul 13

Grifols (GRFS) Launches FESILTY in the U.S. for Congenital Fibrinogen Deficiency Treatment

Yahoo Finance · Jun 19

Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.

Yahoo Finance · Jun 15

How The Grifols (BME:GRF) Investment Story Is Shifting With New Analyst Caution

Yahoo Finance · May 23

European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading

Yahoo Finance · Jun 9

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday

Yahoo Finance · May 28

Headlines via Yahoo Finance · links open the source · not an endorsement.

Research & reports

TradingView ↗

Charts & analysis

Yahoo Finance ↗

Quote & news

External resources — availability and opinions are theirs, not ours.

This is reference data for your own analysis — not a recommendation to buy or sell GRF.MC. Try it in the Lab to size a position and see the risk.